Refine your search

Clear

Search Results

Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.

1 Study Matches

Site for A 12-Week Double-Blind, Placebo-Controlled Randomized Phase 2 Trial with a 12-Week Open-Label Extension to Determine the Immunomodulatory Activity of PTM-001 in Patients with Hidradenitis Suppurativa

Hidradenitis Suppurativa (HS): Assigned to PTM-001 (400mg) or placebo (no active ingredients) for 12 weeks after which all patients will receive the actual study medication, PTM-001 400mg daily for an additional 12 weeks. Males/Females 18 years of age and older. The goal of the study is assess the effect of PTM-001 on skin protein levels.
Amy Longenecker at alongenecker@pennstatehealth.psu.edu or 717-531-5136
All
18 year(s) or older
This study is NOT accepting healthy volunteers
NCT05020730
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Had onset of symptoms consistent with HS at least 6 months; active HS for at least 2 months
Agrees to follow all study directions
Exclusion Criteria:
Has other skin conditions that could interfere with viewing HS
Positive for TB, HIV, Hepatitis B or Hepatitis C
Certain medications not allowed; study coordinator will discuss
For females: Pregnant, nursing or considering becoming pregnant
Skin Conditions
  Email this study information to me
  Contact the study team
  See more information
  Show all 1 locations

Study Locations

Hide all locations
Location
Hershey, PA